• +91 40 6608 6608
  • info@vivimedlabs.com
  • Live stock info at NSE
  • Live stock info at BSE
  • Login
VivimedlabsVivimedlabs

Welcome to Vivimedlabs

  • Home
  • About
    • Our Company
    • Who We are
    • Vision & Mission
    • Values
    • Management
    • Board of Directors
    • Code of Conduct
  • Business Portfolio
    • Business Model
    • Active Pharmaceutical Ingredients
    • Finished Dosage Formulations
    • R&D
  • Facilities
    • Operational Units
    • Our Accreditations
    • Dosage Forms
  • Product List
  • Investors
    • Financials
    • Corporate Governance
    • Annual Reports
    • Shareholders Information
    • CSR
  • News & Events
    • Awards & Achievements
  • Contact Us
    • Careers
    • Contact Us

Monthly Archives: August 2018

Vivimedlabs   →  2018   →  August
08
Aug
Date August 8, 2018
Categories News

Appointment of the group CEO, Ramesh Krishnamurthy

It gives us great pleasure in welcoming Mr Ramesh Krishnamurthy into the Vivimed family.
Read More
Author sqenta

Categories

  • News 4

Recent Posts

  • Vivimed Launches its own brand of favipiravir, FavulousAugust 9, 2020
  • Appointment of the group CEO, Ramesh KrishnamurthyAugust 8, 2018
  • 2018- acquisition of Soneas, a CDMO based out of Budapest, Hungary.September 2, 2020
  • Orbimed Asia invests in UQUIFA, the API entity of Vivimed LabsSeptember 2, 2020

Archives

  • September 2020
  • August 2020
  • August 2018
Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated Readmore

About

  • Our Company
  • Who We are
  • Vision & Mission
  • Values
  • Management
  • Board of Directors
  • Code of Conduct

Business Portfolio

  • Business Model
  • Active Pharmaceutical Ingredients
  • Finished Dosage Formulations
  • R&D

Investors

  • Financials
  • Corporate Governance
  • Annual Reports
  • Shareholders Information
  • Other Data
© Copyright 2016-2020. All Rights Reserved

Powered by Sqenta